TrialClinical drug investigation2018

Safety and Pharmacokinetics of DS-8500a, a Novel GPR119 Agonist, After Multiple Oral Doses in Healthy Japanese Males.

Manabu Kato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.